122 related articles for article (PubMed ID: 19724165)
21. [Cholesterol metabolism modulators in future drug therapy for atherosclerosis].
Morozova S; Suc-Royer I; Auwerx J
Med Sci (Paris); 2005 Dec; 21 Spec No():53-8. PubMed ID: 16598906
[TBL] [Abstract][Full Text] [Related]
22. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
Brown SA; Guise TA
Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
[TBL] [Abstract][Full Text] [Related]
23. Medical treatment of Charcot neuroosteoarthropathy.
Jostel A; Jude EB
Clin Podiatr Med Surg; 2008 Jan; 25(1):63-9, vi-vii. PubMed ID: 18165112
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
Blair MM; Carson DS; Barrington R
J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
[TBL] [Abstract][Full Text] [Related]
25. The use of bisphosphonates in cancer patients.
Wu S; Dahut WL; Gulley JL
Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
Chapman MJ
Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
[TBL] [Abstract][Full Text] [Related]
27. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
28. Identification of dynamin-2-mediated endocytosis as a new target of osteoporosis drugs, bisphosphonates.
Masaike Y; Takagi T; Hirota M; Yamada J; Ishihara S; Yung TM; Inoue T; Sawa C; Sagara H; Sakamoto S; Kabe Y; Takahashi Y; Yamaguchi Y; Handa H
Mol Pharmacol; 2010 Feb; 77(2):262-9. PubMed ID: 19903825
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of bisphosphonates in cancer therapy.
Lüftner D; Henschke P; Possinger K
Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
[TBL] [Abstract][Full Text] [Related]
31. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
[TBL] [Abstract][Full Text] [Related]
32. Who will benefit from antiresorptive treatment (bisphosphonates)?
Papapoulos SE
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease and osteoporosis: is there a link between lipids and bone?
Burnett JR; Vasikaran SD
Ann Clin Biochem; 2002 May; 39(Pt 3):203-10. PubMed ID: 12038594
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of osteoporosis in octogenarians].
Pepersack T
Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonates: mode of action and pharmacology.
Russell RG
Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
[TBL] [Abstract][Full Text] [Related]
36. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
37. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
38. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic effects of oral bisphosphonates on the intestine.
Pazianas M; Russell RG
Ann N Y Acad Sci; 2011 Dec; 1240():E19-25. PubMed ID: 22360293
[TBL] [Abstract][Full Text] [Related]
40. [The use of bisphosphonates for treating pathological states in orthopedics].
Białecki P; Bohatyrewicz A; Machoy-Mokrzyńska A; Białecka M
Chir Narzadow Ruchu Ortop Pol; 2008; 73(4):266-73. PubMed ID: 18847019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
